Joanna G Katzman

Dr. Joanna G Katzman

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
SASanjeev Arora
Sanjeev Arora
SKSummers Kalishman
Summers Kalishman
KTKarla Thornton
Karla Thornton
DDDenise Dion
Denise Dion
GMGlen Murata
Glen Murata
WPWesley Pak
Wesley Pak
The Extension for Community Healthcare Outcomes (ECHO) Model was developed by the University of New Mexico Health Sciences Center as a platform to deliver complex specialty medical care to underserved populations through an innovative educational model of team-based interdisciplinary development. Using state-of-the-art telehealth technology, best practice protocols, and case-based learning, ECHO trains and supports primary care providers to develop knowledge and self-efficacy on a variety of diseases. As a result, they can deliver best practice care for complex health conditions in communities where specialty care is unavailable. ECHO was first developed for the management of hepatitis C virus (HCV), optimal management of which requires consultation with multidisciplinary experts in medical specialties, mental health, and substance abuse. Few practitioners, particularly in rural and underserved areas, have the knowledge to manage its emerging treatment options, side effects, drug toxicities, and treatment-induced depression. In addition, data were obtained from observation of ECHO weekly clinics and database of ECHO clinic participation and patient presentations by clinical provider. Evaluation of the ECHO program incorporates an annual survey integrated into the ECHO annual meeting and routine surveys of community providers about workplace learning, personal and professional experiences, systems and environmental factors associated with professional practice, self-efficacy, facilitators, and barriers to ECHO. The initial survey data show a significant improvement in provider knowledge, self-efficacy, and professional satisfaction through participation in ECHO HCV clinics. Clinicians reported a moderate to major benefit from participation. We conclude that ECHO expands access to best practice care for underserved populations, builds communities of practice to enhance professional development and satisfaction of primary care clinicians, and expands sustainable capacity for care by building local centers of excellence.

1 June 2011 in Health Affairs
Verified
Journal Article
Closed access
SASanjeev Arora
Sanjeev Arora
SKSummers Kalishman
Summers Kalishman
DDDenise Dion
Denise Dion
DSDara Som
Dara Som
KTKarla Thornton
Karla Thornton
SYSean Yutzy
Sean Yutzy
Many of the estimated thirty-two million Americans expected to gain coverage under the Affordable Care Act are likely to have high levels of unmet need because of various chronic illnesses and to l...

1 January 2014 in Journal of Continuing Education in the Health Professions
Verified
Journal Article
Closed access
PDF file
JKJoanna G Katzman
Joanna G Katzman
GCGeorge Comerci
George Comerci
JBJeannie F. Boyle
Jeannie F. Boyle
DDDaniel Duhigg
Daniel Duhigg
BSBrian Shelley
Brian Shelley
SASanjeev Arora
Sanjeev Arora

5 February 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JKJoanna G Katzman
Joanna G Katzman
MTMikiko Y. Takeda
Mikiko Y. Takeda
NGNina Greenberg
Nina Greenberg
MBMonica Moya Balasch
Monica Moya Balasch
AAAmal Alchbli
Amal Alchbli
SBSnehal R. Bhatt
Snehal R. Bhatt
In the US in 2018, on average, 130 individuals died every day from an unintentional overdose (OD) of prescription opioid analgesics or injection heroin.1 Opioid use disorder (OUD) may develop in many ways, including use of prescription opioid analgesics given to patients for legitimate chronic pain, misuse of prescription opioids borrowed from a friend or relative for chronic pain, and illicit use of injection heroin.2 Almost one-half of all prescription opioid–related emergency department visits are the result of nonmedical opioid use.3 Medication-assisted treatment and increased availability of naloxone are considered best practices for reducing patient mortality associated with OUD.4

1 January 2021 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
PDF file
JKJoanna G Katzman
Joanna G Katzman
JKJeffrey W. Katzman
Jeffrey W. Katzman
The development of highly efficacious COVID-19 vaccines has brought a feeling of hope to many in the US (United States) and across the globe. However, it is estimated that approximately one-third of the US and international population are hesitant to receive the COVID-19 vaccine. For most Western countries with the economic means to purchase sufficient vaccine for their citizens, the medical community now has the opportunity to lead the vaccination communication campaign. Because frontline clinicians were the first to be vaccinated in the United States (US), they are uniquely positioned to be the most trusted source of vaccine information. Primary care clinicians, more than other groups of clinicians, scientists, government officials, media, etc. have the greatest chance for instilling confidence about the vaccine to their patients, including the most vulnerable and the most distrusting. They are considered credible and trustworthy allies for their patients in the US, however, clinicians receive little to no formal training in communication related to controversial topics, such as vaccine hesitancy. With the increasing worry about highly transmissible COVID-19 viral mutations and possible related vaccine resistance, it becomes even more critical to accelerate vaccination efforts across every community. Educating primary care clinicians regarding the importance of talking to their patients regarding their COVID-19 vaccination plans is essential.

31 October 2018 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
JKJoanna G Katzman
Joanna G Katzman
CQClifford R. Qualls
Clifford R. Qualls
WSWilliam A. Satterfield
William A. Satterfield
MKMartin Kistin
Martin Kistin
KHKeith Hofmann
Keith Hofmann
SASanjeev Arora
Sanjeev Arora
Background Opioid overdose deaths occur in civilian and military populations and are the leading cause of accidental death in the USA. Objective To determine whether ECHO Pain telementoring regarding best practices in pain management and safe opioid prescribing yielded significant declines in opioid prescribing. Design A 4-year observational cohort study at military medical treatment facilities worldwide. Participants Patients included 54.6% females and 46.4% males whose primary care clinicians (PCCs) opted to participate in ECHO Pain; the comparison group included 39.9% females and 60.1% males whose PCCs opted not to participate in ECHO Pain. Intervention PCCs attended 2-h weekly Chronic Pain and Opioid Management TeleECHO Clinic (ECHO Pain), which included pain and addiction didactics, case-based learning, and evidence-based recommendations. ECHO Pain sessions were offered 46 weeks per year. Attendance ranged from 1 to 3 sessions (47.7%), 4–19 (32.1%, or > 20 (20.2%). Main Measures This study assessed whether clinician participation in Army and Navy Chronic Pain and Opioid Management TeleECHO Clinic (ECHO Pain) resulted in decreased prescription rates of opioid analgesics and co-prescribing of opioids and benzodiazepines. Measures included opioid prescriptions, morphine milligram equivalents (MME), and days of opioid and benzodiazepine co-prescribing per patient per year. Key Results PCCs participating in ECHO Pain had greater percent declines than the comparison group in (a) annual opioid prescriptions per patient (− 23% vs. − 9%, P < 0.001), (b) average MME prescribed per patient/year (−28% vs. −7%, p < .02), (c) days of co-prescribed opioid and benzodiazepine per opioid user per year (−53% vs. −1%, p < .001), and (d) the number of opioid users (−20.2% vs. −8%,p < .001). Propensity scoring transformation–adjusted results were consistent with the opioid prescribing and MME results. Conclusions Patients treated by PCCs who opted to participate in ECHO Pain had greater declines in opioid-related prescriptions than patients whose PCCs opted not to participate.